A prospective, observational, cohort study assessing the early exploration of COVID-19 vaccination safety and effectiveness during pregnancy
Latest Information Update: 12 Oct 2021
Price :
$35 *
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 12 Oct 2021 New trial record
- 25 Sep 2021 Interim results published in the Vaccine